STOCK TITAN
  1. Home
  2. Sec-filings
  3. LMAT
  4. [Form 4] LEMAITRE VASCULAR INC Insider Trading Activity

LeMaitre (NASDAQ: LMAT) director gets dividend equivalent right awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Roush John A reported acquisition or exercise transactions in this Form 4 filing.

LeMaitre Vascular director John A. Roush reported routine compensation-related transactions in the form of dividend equivalent rights on June 4, 2026. Five separate grants of dividend equivalent rights were credited in fractional amounts, each tied to existing restricted stock unit and performance share unit awards granted in December 2023, 2024, and 2025. Each dividend equivalent right is the economic equivalent of one share of LeMaitre Vascular common stock and vests in step with the underlying equity awards. These awards involve no cash paid by Roush and do not reflect any open-market purchases or sales of shares.

Positive

  • None.

Negative

  • None.
Insider Roush John A
Role null
Type Security Shares Price Value
Grant/Award Dividend Equivalent Rights 0.466 $0.00 --
Grant/Award Dividend Equivalent Rights 0.558 $0.00 --
Grant/Award Dividend Equivalent Rights 0.76 $0.00 --
Grant/Award Dividend Equivalent Rights 0.86 $0.00 --
Grant/Award Dividend Equivalent Rights 1.427 $0.00 --
Holdings After Transaction: Dividend Equivalent Rights — 5.067 shares (Direct, null)
Footnotes (1)
  1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend equivalent rights grant 1 1.4274 rights Grant on June 4, 2026 tied to 12/8/2023 RSU
Dividend equivalent rights grant 2 0.8599 rights Grant on June 4, 2026 tied to 12/8/2023 PSU
Dividend equivalent rights grant 3 0.7595 rights Grant on June 4, 2026 tied to 12/6/2024 RSU
Dividend equivalent rights grant 4 0.5579 rights Grant on June 4, 2026 tied to 12/6/2024 PSU
Dividend equivalent rights grant 5 0.4658 rights Grant on June 4, 2026 tied to 12/10/2025 RSU
Rights after last transaction 5.0674 rights Total dividend equivalent rights following final June 4, 2026 entry
Dividend Equivalent Rights financial
"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
restricted stock unit award financial
"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023"
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
performance share unit award financial
"These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023"
economic equivalent of one share financial
"Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Roush John A
(Last)(First)(Middle)
C/O LEMAITRE VASCULAR, 63 SECOND AVENUE
(Street)
BURLINGTON MASSACHUSETTS 01803
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Dividend Equivalent Rights(1)06/04/2026A0.4658 (1) (1)Common Stock0.4658$05.0674D
Dividend Equivalent Rights(2)06/04/2026A0.5579 (2) (2)Common Stock0.5579$04.8692D
Dividend Equivalent Rights(3)06/04/2026A0.7595 (3) (3)Common Stock0.7595$04.2984D
Dividend Equivalent Rights(4)06/04/2026A0.8599 (4) (4)Common Stock0.8599$04.4838D
Dividend Equivalent Rights(5)06/04/2026A1.4274 (5) (5)Common Stock1.4274$02.6351D
Explanation of Responses:
1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
/s/ Laurie A. Churchill, Attorney-in-fact06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did LeMaitre (LMAT) director John A. Roush report in this Form 4?

John A. Roush reported grants of dividend equivalent rights on existing equity awards. These are compensation-related credits that mirror dividends on common stock and vest alongside his restricted stock unit and performance share unit grants.

Were any LeMaitre (LMAT) shares bought or sold in this Form 4?

No open-market share purchases or sales occurred. The Form 4 only shows grants of dividend equivalent rights, which are bookkeeping entries tied to prior stock-based awards, not discretionary stock trades in the market.

What are dividend equivalent rights for LeMaitre (LMAT) awards?

Dividend equivalent rights are credits that mirror dividends on LeMaitre common stock for unvested equity awards. Each right is the economic equivalent of one share and generally vests proportionately with the related restricted stock unit or performance share unit.

Which LeMaitre (LMAT) awards generated these dividend equivalent rights?

The dividend equivalent rights accrued on restricted stock unit and performance share unit awards granted on December 8, 2023, December 6, 2024, and December 10, 2025. Each grant’s rights vest proportionately with its underlying award schedule.

Does this LeMaitre (LMAT) Form 4 change John A. Roush’s ownership materially?

The filing reflects small fractional dividend equivalent rights credited as part of compensation. These derivative entries modestly increase his economic exposure but do not represent large or market-driven changes in his share ownership.